Is upregulation of BCL2 a determinant of tumor development driven by inactivation of CDH1/E-cadherin?
about
Lobular breast cancer: molecular basis, mouse and cellular models.E-cadherin-mediated impairment increases anti-apoptotic mechanism through upregulation of Bcl-2: An immunohistochemical study in various patterns of invasion of oral squamous cell carcinoma.Lobular carcinoma in situ and invasive lobular breast cancer are characterized by enhanced expression of transcription factor AP-2β.
P2860
Is upregulation of BCL2 a determinant of tumor development driven by inactivation of CDH1/E-cadherin?
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Is upregulation of BCL2 a dete ...... activation of CDH1/E-cadherin?
@ast
Is upregulation of BCL2 a dete ...... activation of CDH1/E-cadherin?
@en
Is upregulation of BCL2 a dete ...... activation of CDH1/E-cadherin?
@nl
type
label
Is upregulation of BCL2 a dete ...... activation of CDH1/E-cadherin?
@ast
Is upregulation of BCL2 a dete ...... activation of CDH1/E-cadherin?
@en
Is upregulation of BCL2 a dete ...... activation of CDH1/E-cadherin?
@nl
prefLabel
Is upregulation of BCL2 a dete ...... activation of CDH1/E-cadherin?
@ast
Is upregulation of BCL2 a dete ...... activation of CDH1/E-cadherin?
@en
Is upregulation of BCL2 a dete ...... activation of CDH1/E-cadherin?
@nl
P2093
P2860
P1433
P1476
Is upregulation of BCL2 a dete ...... activation of CDH1/E-cadherin?
@en
P2093
Elisa Schipper
Hans Kreipe
Henriette Christgen
Inga Karch
Matthias Christgen
Ulrich Lehmann
P2860
P304
P356
10.1371/JOURNAL.PONE.0073062
P407
P577
2013-08-30T00:00:00Z